Dianthus Therapeutics, Inc. · NASDAQ:DNTH
Soteropoulos Paula sold 599 Dianthus Therapeutics, Inc. shares (Form 4)
Traded May 8, 2026 · Filed May 11, 2026
On May 8, 2026, Soteropoulos Paula (Director) sold 599 Dianthus Therapeutics, Inc. shares at US$85.47 for US$51,197 under a trading plan, leaving 0 shares. Filed May 11, 2026 (Form 4).
- Sold
- 599 shares
- Price
- US$85.47
- Value
- US$51,197
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 8, 2026 | Common Stock | Option exercise | 599 | US$8.44 | 599 | Direct |
| May 8, 2026 | Common Stock | Sale | 599 | US$85.47 | 0 | Direct |
Source
Related
- Dianthus Therapeutics, Inc.
- Soteropoulos Paula
- Dianthus Therapeutics, Inc. shareholders
- Form 4 · Soteropoulos Paula · Apr 1, 2026
- Form 4 · Carr Edward · Sep 18, 2026
- Form 4 · Randhawa Simrat · Sep 3, 2026
- Form 4 · Read Simon · Aug 19, 2026
- Form 4 · Veness Adam M · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026